- JP-listed companies
- KANEKA CORPORATION
- Financials
- EBITDA margin (%)
KANEKA CORPORATION (4118)
Market cap
¥327.6B
P/E ratio
9.7x
Kaneka develops advanced materials, medical devices, solar technology, and nutrition products across four business units serving infrastructure, housing, healthcare, and food industries.
| Period End | EBITDA margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 10.4 | +8.12% |
| Mar 31, 2024 | 9.6 | -2.43% |
| Mar 31, 2023 | 9.9 | -16.33% |
| Mar 31, 2022 | 11.8 | +6.67% |
| Mar 31, 2021 | 11.1 | +10.13% |
| Mar 31, 2020 | 10 | -8.62% |
| Mar 31, 2019 | 11 | -2.61% |
| Mar 31, 2018 | 11.3 | +1.37% |
| Mar 31, 2017 | 11.1 | -4.50% |
| Mar 31, 2016 | 11.6 | +32.93% |
| Mar 31, 2015 | 8.8 |